Prades-le-Lez, France

Gudrun Aldrian-Herrada




Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 169(Granted Patents)


Company Filing History:


Years Active: 2009-2012

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Gudrun Aldrian-Herrada: Innovator in Cell-Penetrating Peptides

Introduction

Gudrun Aldrian-Herrada is a notable inventor based in Prades-le-Lez, France. She has made significant contributions to the field of biotechnology, particularly in the development of cell-penetrating peptides (CPPs). With a total of three patents to her name, her work focuses on enhancing the delivery of molecules into cells.

Latest Patents

Aldrian-Herrada's latest patents include innovative cell-penetrating peptides designed for intracellular delivery of various molecules. One of her inventions features a specific amino acid sequence, GLXRALXRXLXRSLXXXXXXX, which allows for the effective transport of nucleic acids, proteins, and peptides into cells, both in vitro and in vivo. Another patent presents a similar CPP with the sequence GLXWRAXWRXLXRSLXWXXXXXX, further expanding the potential applications of these peptides in biomedical research and therapy.

Career Highlights

Throughout her career, Aldrian-Herrada has worked with prominent organizations such as Affymetrix, Inc. and the Centre De La Recherche Scientifique. Her experience in these institutions has contributed to her expertise in molecular biology and peptide technology.

Collaborations

Aldrian-Herrada has collaborated with esteemed colleagues, including Gilles Divita and Frédéric Heitz, to advance her research and innovations in the field of cell-penetrating peptides.

Conclusion

Gudrun Aldrian-Herrada's work in developing cell-penetrating peptides has the potential to revolutionize the delivery of therapeutic agents in medicine. Her contributions to biotechnology continue to pave the way for future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…